Erudio Healtherudio.com
Sponsor
Emory University trials: what clinicians said in public
No HCP commentary report on a trial sponsored by Emory University yet. Erudio has found public clinician commentary on 4 clinical trials sponsored by Emory University: EMPIRE-1, NCT03579771, NCT04393350 and NCT05756569. Each trial's page lists the podcasts, videos and posts found so far and the price of a report.
Listed by lead sponsor as registered on ClinicalTrials.gov (Emory University). A trial led by a partner or a research group is on that sponsor's page. Only trials with public clinician commentary found are listed, not every trial the sponsor runs.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| EMPIRE-1 NCT01666808 · Emory University StandardView → | prostate cancer receiving post-prostatectomy radiotherapy | Phase 2/Phase 3 | Standard | View | |||
| NCT03579771 NCT03579771 · Emory University FocusedView → | resectable high-risk intrahepatic cholangiocarcinoma | Phase 2 | Focused | View | |||
| NCT05756569 NCT05756569 · Emory University FocusedView → | Not given | Phase 2 | Focused | View | |||
| NCT04393350 NCT04393350 · Emory University FocusedView → | locally advanced nonmetastatic clear cell renal cell carcinoma | Phase 2 | Focused | View | |||